本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Veru Inc.

2.57
+0.03001.18%
成交量:2.28万
成交额:5.80万
市值:4,124.95万
市盈率:-1.15
高:2.61
开:2.61
低:2.50
收:2.54
52周最高:14.20
52周最低:2.42
股本:1,605.04万
流通股本:1,448.04万
量比:1.01
换手率:0.16%
股息:- -
股息率:- -
每股收益(TTM):-2.2335
每股收益(LYR):-2.8027
净资产收益率:-106.02%
总资产收益率:-52.13%
市净率:2.69
市盈率(LYR):-0.92

数据加载中...

公司资料

公司名字:
Veru Inc.
交易所:
NASDAQ
成立时间:
1971
员工人数:
210
公司地址:
2916 North Miami Avenue,Suite 1000,Miami,Florida,United States
邮编:
33127
电话:
传真:
- -
简介:
Veru Inc.成立于1971年。是一家临床后期生物制药公司,专注于开发治疗代谢性疾病、肿瘤学、ARDS的新药。该公司的药物开发计划包括两个晚期新化学实体,enobosarm和sabizabulin。

董事

名称
职位
Harry Fisch
Director,Vice Chairman of the Board,Chief Corporate Officer
Mitchell S. Steiner
President and Chief Executive Officer and Director,Chairman of the Board
Grace Hyun
Director
Lucy Lu
Director
Mario Eisenberger
Director
Michael L. Rankowitz
Director

股东

名称
职位
Mitchell S. Steiner
President and Chief Executive Officer and Director,Chairman of the Board
Michele Greco
Chief Financial Officer and Chief Administrative Officer
Harry Fisch
Director,Vice Chairman of the Board,Chief Corporate Officer
K. Gary Barnette
Chief Scientific Officer